PR Newswire BiotechOriginal article
Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference
ConferenceDCVaxNeutral
AI Analysis
Summary
Northwest Biotherapeutics announced that its Chief Technical Officer, Dr. Marnix Bosch, will deliver a keynote presentation on personalized, multi-target immunotherapy approaches to cancer at the UK National Health Service Annual Oncology Conference.
Importance:2/10
Sentiment:
0.00
immunotherapypersonalized medicineoncologyconference presentationDCVax
Related Companies
Read the original article
Published by PR Newswire Biotech on October 6, 2026 7:00 AM
